0 التعليقات
0 المشاركات
312 مشاهدة
0 معاينة
البحث
إكتشاف أشخاص جدد وإنشاء اتصالات جديدة وصداقات جديدة
-
الرجاء تسجيل الدخول , للأعجاب والمشاركة والتعليق على هذا!
-
Advanced Renal Cell Carcinoma Therapeutics Market: 7.3% CAGR Growth Through 2030According to a newly published market research report by 24LifeSciences, global advanced renal cell carcinoma therapeutics market was valued at USD 3.2 billion in 2023 and is projected to reach USD 5.8 billion by 2030, growing at a compound annual growth rate (CAGR) of 7.3% during the forecast period 20242030. Advanced renal cell carcinoma therapeutics encompass targeted therapies,...0 التعليقات 0 المشاركات 323 مشاهدة 0 معاينة
-
Basal Cell Carcinoma Therapeutics Market to Reach USD 14.6 Billion by 2032 | CAGR 7.3%According to a newly published market research report by 24LifeSciences, global basal cell carcinoma therapeutics market was valued at USD 8.2 billion in 2024 and is projected to reach USD 14.6 billion by 2032, growing at a compound annual growth rate (CAGR) of 7.3% during the forecast period 2025-2032. Basal Cell Carcinoma (BCC), the most common form of skin cancer accounting for...0 التعليقات 0 المشاركات 5كيلو بايت مشاهدة 0 معاينة
-
Bispecific T Cell Engager Therapeutics Market to Grow at 15.8% CAGR (2025–2032)According to a newly published market research report by 24LifeSciences, global bispecific T cell engager therapeutics market was valued at USD 5.8 billion in 2024 and is projected to reach USD 20.1 billion by 2032, growing at a compound annual growth rate (CAGR) of 15.8% during the forecast period 20252032. Bispecific T cell engagers (BiTEs) represent a revolutionary class of...0 التعليقات 0 المشاركات 283 مشاهدة 0 معاينة
-
Bispecific T Cell Engager Therapeutics Market to Grow at 15.8% CAGR (2025–2032)According to a newly published market research report by 24LifeSciences, global bispecific T cell engager therapeutics market was valued at USD 5.8 billion in 2024 and is projected to reach USD 20.1 billion by 2032, growing at a compound annual growth rate (CAGR) of 15.8% during the forecast period 20252032. Bispecific T cell engagers (BiTEs) represent a revolutionary class of...0 التعليقات 0 المشاركات 270 مشاهدة 0 معاينة
-
Global Bispecific T-Cell Engager (BiTE) Therapeutics Market: 15.8% CAGR to Reach USD 20.1 Billion by 2032According to a newly published market research report by 24LifeSciences, global bispecific T cell engager therapeutics market was valued at USD 5.8 billion in 2024 and is projected to reach USD 20.1 billion by 2032, growing at a compound annual growth rate (CAGR) of 15.8% during the forecast period 20252032. Bispecific T cell engagers (BiTEs) represent a revolutionary class of...0 التعليقات 0 المشاركات 212 مشاهدة 0 معاينة
-
Global Bispecific T-Cell Engager (BiTE) Therapeutics Market: 15.8% CAGR to Reach USD 20.1 Billion by 2032According to a newly published market research report by 24LifeSciences, global bispecific T cell engager therapeutics market was valued at USD 5.8 billion in 2024 and is projected to reach USD 20.1 billion by 2032, growing at a compound annual growth rate (CAGR) of 15.8% during the forecast period 20252032. Bispecific T cell engagers (BiTEs) represent a revolutionary class of...0 التعليقات 0 المشاركات 200 مشاهدة 0 معاينة
-
Mantle Cell Lymphoma Therapeutics Market to Reach USD 2.78 Billion by 2034, Driven by Advances in Targeted Therapies and CAR-T InnovationsAccording to a new report from Intel Market Research, the global Mantle Cell Lymphoma Therapeutics market was valued at USD 1.45 billion in 2025 and is projected to reach USD 2.78 billion by 2034, growing at a steady CAGR of 7.8% during the forecast period (2026–2034). This expansion reflects growing clinical adoption of novel targeted therapies and increasing healthcare investments in...0 التعليقات 0 المشاركات 1كيلو بايت مشاهدة 0 معاينة
-
Non-Small Cell Lung Cancer Therapeutics Market Research Report: Insights and Forecast 2034The rising burden of lung cancer cases worldwide is driving significant advancements in therapeutic innovation. Increasing adoption of precision medicine, immunotherapy, and targeted treatment approaches is reshaping the treatment landscape for patients diagnosed with non-small cell lung cancer. Healthcare providers and pharmaceutical companies are investing heavily in research activities to...0 التعليقات 0 المشاركات 215 مشاهدة 0 معاينة
-
Small Cell Lung Cancer Therapeutics Market Outlook: 6.8% CAGR Growth Through 2031According to a newly published market research report by 24LifeSciences, the global Small Cell Lung Cancer therapeutics market was valued at USD 2.1 billion in 2024 and is projected to reach USD 3.5 billion by 2031, growing at a compound annual growth rate (CAGR) of 6.8% during the forecast period 20252031. Small Cell Lung Cancer (SCLC) is an aggressive neuroendocrine malignancy accounting for...0 التعليقات 0 المشاركات 219 مشاهدة 0 معاينة
-
Small Cell Lung Cancer Therapeutics Market Outlook: 6.8% CAGR Growth Through 2031According to a newly published market research report by 24LifeSciences, the global Small Cell Lung Cancer therapeutics market was valued at USD 2.1 billion in 2024 and is projected to reach USD 3.5 billion by 2031, growing at a compound annual growth rate (CAGR) of 6.8% during the forecast period 20252031. Small Cell Lung Cancer (SCLC) is an aggressive neuroendocrine malignancy accounting for...0 التعليقات 0 المشاركات 211 مشاهدة 0 معاينة
-
Market Intelligence: Basal Cell Carcinoma Treatment Trends and DriversHealthcare infrastructure improvements are enhancing access to skin cancer treatments.Specialized dermatology centers are expanding globally.This accessibility is contributing to increased treatment adoption The Basal Cell Carcinoma Treatment Market is expected to register a CAGR of 9.3% from 2025 to 2031, with market size rising from US$ XX million in 2024 to US$ XX Million by 2031. The market...0 التعليقات 0 المشاركات 4كيلو بايت مشاهدة 0 معاينة1
-
Transformative Healthcare Evolution: Vaccine, Indulin, and Stem Cell Market Trends, Growth Analysis, and Forecast to 2034The Vaccine, Indulin, and Stem Cell Market Analysis demonstrates a rapidly advancing global healthcare sector fueled by innovation in biologics, regenerative medicine, and chronic disease management. According to insights from The Insight Partners, the market is projected to grow at a compound annual growth rate (CAGR) of approximately 13.1% during 2026–2034, reflecting strong expansion...0 التعليقات 0 المشاركات 2كيلو بايت مشاهدة 0 معاينة
الصفحات المعززة